AAV-PHP.C2 Serotype
Third-generation CREATE variant engineered for enhanced cardiac tropism with maintained BBB penetration capability.
Characteristics
Third-generation CREATE selection targeting cardiac tissue. Enhanced cardiomyocyte transduction. Retains some CNS penetration. Reduced liver uptake compared to AAV9.
Applications: Cardiac gene therapy in mice. Heart failure research models. Dual cardiac-CNS applications.
References
- Challis et al. (2019). Systemic AAV vectors for widespread and targeted gene delivery in rodents. Nat Protoc - Challis 2019 PHP.C